PCNA expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.147000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.721600E-01
Normal-vs-Stage2
7.886400E-01
Normal-vs-Stage3
5.609200E-01
Normal-vs-Stage4
7.161200E-01
Stage1-vs-Stage2
9.018400E-01
Stage1-vs-Stage3
5.102800E-01
Stage1-vs-Stage4
6.389800E-01
Stage2-vs-Stage3
3.447200E-01
Stage2-vs-Stage4
4.864600E-01
Stage3-vs-Stage4
8.372800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.851400E-01
Normal-vs-AfricanAmerican
9.628400E-01
Normal-vs-Asian
8.996400E-01
Caucasian-vs-AfricanAmerican
3.042200E-01
Caucasian-vs-Asian
4.852800E-01
AfricanAmerican-vs-Asian
8.868000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.462400E-01
Normal-vs-Female
6.881400E-01
Male-vs-Female
1.406850E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.580400E-02
Normal-vs-Age(41-60Yrs)
7.115800E-01
Normal-vs-Age(61-80Yrs)
8.738200E-01
Normal-vs-Age(81-100Yrs)
5.765800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.015420E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.657900E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.817900E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.602600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.190200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.235800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.162800E-01
Normal-vs-Daily Drinker
8.939200E-01
Normal-vs-Weekly Drinker
6.705200E-01
Normal-vs-Occasional Drinker
3.127200E-01
Normal-vs-Social Drinker
8.457600E-01
Non Drinker-vs-Daily Drinker
6.260800E-01
Non Drinker-vs-Weekly Drinker
4.444000E-01
Non Drinker-vs-Occasional Drinker
1.287830E-01
Non Drinker-vs-Social Drinker
8.236000E-01
Daily Drinker-vs-Weekly Drinker
3.166400E-01
Daily Drinker-vs-Occasional Drinker
3.914100E-02
Daily Drinker-vs-Social Drinker
5.394800E-01
Weekly Drinker-vs-Occasional Drinker
9.740000E-01
Weekly Drinker-vs-Social Drinker
5.584800E-01
Occasional Drinker-vs-Social Drinker
3.102400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.502800E-01
Normal-vs-Grade 2
6.799000E-01
Normal-vs-Grade 3
7.084800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.417620E-01
Grade 1-vs-Grade 3
2.993700E-02
Grade 1-vs-Grade 4
6.502800E-01
Grade 2-vs-Grade 3
1.537050E-01
Grade 2-vs-Grade 4
6.799000E-01
Grade 3-vs-Grade 4
7.084800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.277400E-01
Normal-vs-NonDiabetic
7.772200E-01
Diabetic-vs-NonDiabetic
2.441400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.459800E-01
Normal-vs-NoPancreatitis
8.113000E-01
Pancreatitis-vs-NoPancreatitis
1.074400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.055600E-01
Normal-vs-N1
8.081200E-01
N0-vs-N1
8.884000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.993600E-01
Normal-vs-TP53-NonMutant
8.604800E-01
TP53-Mutant-vs-TP53-NonMutant
1.134010E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
